VEGF ,hypoxia-inducible factor ,HIF ,EPO ,erythropoietin ,hypoxia ,angiogenesis ,Reactive oxygen species ,ROS ,nitric oxide ,tissue remodeling ,prolyl hydroxylase domain ,HIF stabilizer ,erythropoiesis ,HIF inhibitors ,tumor vascularization ,tumor growth

monoclonal antibody ,immunotherapy ,tumor antigen ,checkpoint ,PD-1/PD-L1 ,VEGF ,EGFR ,CD38 ,GD2 ,SLAMF7 ,CTLA-4 ,CCR4 ,CD20 ,PDGFR alpha ,HER2 ,VEFGR2 ,CD19 ,antibody-drug conjugates ,ADCs